Skip to main content

Advertisement

Table 4 Incidence of AEs within 30 days before surgery according to CTCAE and Clavien-Dindo gradesa

From: Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy

  CD0 group (n = 61) CD1/2 group (n = 44) CD3/4 group (n = 10) Total (n = 115) P Value
Anemia      0.724
     Grade 0 23 (20.0) 13 (11.3) 2 (1.7) 38 (33.0)  
     Grade 1/2 36 (31.3) 30 (26.1) 8 (7.0) 74 (64.3)  
     Grade 3/4 2 (1.7) 1 (0.9) 0 (0.0) 3 (2.6)  
Leukopenia     0.196
     Grade 0 38 (33.0) 27 (23.5) 10 (8.7) 75 (65.2)  
     Grade 1/2 19 (16.5) 15 (13.0) 0 (0.0) 34 (29.6)  
     Grade 3/4 4 (3.5) 2 (1.7) 0 (0.0) 6 (5.2)  
Neutropenia     0.740
     Grade 0 38 (33.0) 26 (22.6) 8 (7.0) 72 (62.6)  
     Grade 1/2 16 (13.9) 12 (10.4) 2 (1.7) 30 (26.1)  
     Grade 3/4 7 (6.1) 6 (5.2) 0 (0.0) 13 (11.3)  
Lymphocytopenia     0.720
     Grade 0 31 (27.0) 19 (16.5) 6 (5.2) 56 (48.7)  
     Grade 1/2 27 (23.5) 24 (20.9) 4 (3.5) 55 (47.8)  
     Grade 3/4 3 (2.6) 1 (0.9) 0 (0.0) 4 (3.5)  
Thrombocytopenia     0.577
     Grade 0 45 (39.1) 34 (29.6) 9 (7.8) 88 (76.5)  
     Grade 1/2 16 (13.9) 10 (8.7) 1 (0.9) 27 (23.5)  
Total AEs   0.421
     Grade 0 14 (12.2) 8 (7.0) 1 (0.9) 23 (20.0)  
     Grade 1/2 36 (31.3) 28 (24.3) 9 (7.8) 73 (63.5)  
     Grade 3/4 11 (9.6) 8 (7.0) 0 (0.0) 19 (16.5)  
  1. AEs adverse events, CTCAE common terminology criteria for adverse events
  2. aData are presented as number (incidence)